Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal year 2024
Disclosure of inside information pursuant to Article 17 of Regulation (EU) No. 596/2014
Trostberg, July 30, 2024 – Alzchem Group AG is raising its earnings forecasts for fiscal year 2024. Group EBITDA will grow to over EUR 100 million with unchanged sales expectations (original forecast: approx. EUR 90 million). The raise in the EBITDA forecast leads to an increase in the EBITDA margin forecast from previously approx. 15.8% to over 17.5%.
The reason for the increase in the EBITDA forecast is the stronger growth and thus the shift in the product mix towards Specialty Chemicals.
The previous forecasts for the financial performance indicators group sales, inventories, inventory intensity and equity ratio remain unchanged. This results in the following picture for fiscal year 2024:
2023 | Original forecast 2024 | Adjusted forecast 2024 | |
| Group sales | EUR 540.6 million | Growing to around EUR 570 million | Growing to around EUR 570 million |
| Adjusted EBITDA* | EUR 81.4 million | Growing to around EUR 90 million | Growing to over EUR 100 million |
| Adjusted EBITDA margin* | 15.1% | Growing to 15.8% | Growing to over 17.5% |
| Inventories | EUR 107.5 million | Stable | Stable |
| Inventory intensity | 19.9% | Stable | Stable |
| Equity ratio | 38.5% | Growing strongly | Growing strongly |
| * No adjustments were made | |||
Contact
Sabine Sieber
Head of Corporate Communications & Investor Relations
Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany